pentobarbital will decrease the level or outcome of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Use of other therapies is strongly advisable when linagliptin will be to be administered with a CYP3A4 inducerpentobarbital will decrease the level or effect of conivaptan by influencing hepatic/intestinal e